The presence of precipitate found in Dobuject Injection 50mg/ml (Batch no: MA00X7F)

M.B.D. Marketing (S) Pte Ltd would like to update healthcare professionals regarding the presence of precipitation found in the Dobuject Injection from Batch MA00X7F. This precipitate is the crystallisation of dobutamine. The affected batch: MA00X7F, has thus been placed under quarantine. Investigation is ongoing to ascertain that the problem is confined to this batch. Healthcare professionals are strongly advised to visually inspect the Dobuject injection and ensure the absence of particulate matter before the administration of the product. Please refer to the letter for  more details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.